
  
    
      
        Background_NNP
        Two_CD known_VBN enzymes_NNS catabolize_NN the_DT essential_JJ amino_JJ acid_NN
        tryptophan_NN in_IN mammals_NNS ._. Tryptophan_NNP 2_CD ,_, 3_CD dioxygenase_NN (_( TDO_NNP )_) is_VBZ
        expressed_VBN predominantly_RB in_IN hepatic_JJ tissues_NNS and_CC was_VBD the_DT
        first_JJ inducible_JJ enzyme_NN system_NN discovered_VBN in_IN mammals_NNS [_NN 1_CD ]_NN ._.
        It_PRP controls_VBZ serum_NN tryptophan_NN homeostasis_NNS and_CC is_VBZ induced_VBN
        following_VBG ingestion_NN of_IN tryptophan_NN ._. A_DT second_JJ enzyme_NN ,_, IDO_NNP ,_, is_VBZ
        distinguished_VBN from_IN TDO_NNP by_IN its_PRP$ expression_NN pattern_NN ,_, substrate_NN
        specificity_NN and_CC inducibility_NN ._. IDO_NNP is_VBZ expressed_VBN in_IN a_DT variety_NN
        of_IN non-hepatic_JJ tissues_NNS ,_, including_VBG placenta_NN ,_, lung_NN ,_, gut_NN and_CC
        epididymis_NNS [_NN 2_CD ,_, 3_CD ,_, 4_CD ]_NN ._. Except_IN for_IN the_DT last_RB named_VBN tissue_NN
        where_WRB IDO_NNP is_VBZ expressed_VBN constitutively_RB ,_, IDO_NNP is_VBZ inducible_JJ by_IN
        inflammatory_JJ mediators_NNS ,_, including_VBG interferons_NNS ._. In_IN addition_NN ,_,
        IDO_NNP catalyzes_NNS the_DT breakdown_NN of_IN a_DT variety_NN of_IN compounds_NNS which_WDT
        contain_VBP an_DT indole_NN ring_NN ,_, including_VBG D-_NNP tryptophan_NN and_CC
        serotonin_NN ,_, marking_VBG another_DT difference_NN from_IN TDO_NNP ,_, which_WDT is_VBZ
        specific_JJ for_IN L-_NNP tryptophan_NN ._. Curiously_RB ,_, it_PRP appears_VBZ as_IN if_IN
        tryptophan_NN itself_PRP cannot_NN induce_VB IDO_NNP synthesis_NN [_NN 5_CD ]_NN ._. IDO_NNP is_VBZ
        also_RB suggested_VBN to_TO be_VB the_DT evolutionary_JJ ancestor_NN of_IN certain_JJ
        novel_NN myoglobins_NNS which_WDT occur_VBP in_IN molluscs_NNS ,_, marking_VBG IDO_NNP as_IN an_DT
        evolutionarily_RB primitive_JJ enzyme_NN [_NN 6_CD ]_NN ._.
        IDO_NNP is_VBZ known_VBN to_TO be_VB expressed_VBN in_IN cells_NNS infected_VBN with_IN
        intracellular_NN pathogens_NNS such_JJ as_IN 
        Toxoplasma_NNP and_CC 
        Chlamydia_NNP species_NNS and_CC also_RB by_IN viruses_NNS
        [_NN 7_CD ,_, 8_CD ,_, 9_CD ,_, 10_CD ]_NN ._. In_IN the_DT case_NN of_IN 
        Toxoplasma_NNP and_CC 
        Chlamydia_NNP it_PRP has_VBZ been_VBN proposed_VBN that_IN
        IDO_NNP induction_NN is_VBZ a_DT cellular_JJ defense_NN mechanism_NN ,_, designed_VBN to_TO
        limit_VB the_DT proliferation_NN of_IN the_DT invading_VBG pathogen_NN by_IN
        depleting_VBG the_DT essential_JJ amino_JJ acid_NN tryptophan_NN ._. IDO_NNP
        expressed_VBD in_IN monocyte_NN derived_VBD macrophages_NNS has_VBZ also_RB been_VBN
        found_VBN to_TO inhibit_VB the_DT growth_NN of_IN extracellular_NN bacteria_NNS such_JJ
        as_IN group_NN B_NNP streptococci_NN [_NN 11_CD ]_NN ,_, and_CC is_VBZ also_RB induced_VBN in_IN
        tumors_NNS taken_VBN from_IN cancer_NN patients_NNS [_NN 12_CD ]_NN ._. In_IN all_DT of_IN these_DT
        systems_NNS the_DT proximal_NN inducer_NN of_IN IDO_NNP activity_NN is_VBZ
        interferon-γ_JJ (_( IFN-γ_NNP )_) ._. Response_NNP elements_NNS for_IN this_DT cytokine_NN
        have_VBP been_VBN identified_VBN in_IN the_DT human_JJ IDO_NNP promoter_NN and_CC have_VBP
        been_VBN shown_VBN to_TO be_VB essential_JJ for_IN IFN-γ_NNP induction_NN of_IN reporter_NN
        gene_NN expression_NN 
        in_IN vitro_NN [_NN 13_CD ,_, 14_CD ,_, 15_CD ]_NN ._.
        The_DT unusual_JJ tissue_NN distribution_NN of_IN IDO_NNP suggests_VBZ that_IN
        combating_VBG infection_NN is_VBZ not_RB its_PRP$ only_RB function_NN ._. Our_PRP$ interest_NN
        in_IN IDO_NNP arose_VBD when_WRB we_PRP observed_VBD that_DT tryptophan_NN depletion_NN was_VBD
        responsible_JJ for_IN macrophage-induced_JJ inhibition_NN of_IN T_NN cell_NN
        proliferation_NN 
        in_IN vitro_NN [_NN 16_CD ]_NN ._. Furthermore_RB ,_, we_PRP
        reported_VBD that_IN a_DT pharmacologic_JJ inhibitor_NN of_IN IDO_NNP ,_, 1_CD -_: methyl_NN
        tryptophan_NN ,_, induced_VBN maternal_NN rejection_NN of_IN allogeneic_JJ but_CC
        not_RB syngeneic_JJ murine_NN fetuses_NNS [_NN 17_CD ]_NN ._. As_IN IDO_NNP is_VBZ strongly_RB
        expressed_VBN at_IN the_DT maternal-fetal_JJ interface_NN in_IN pregnant_JJ mice_NNS
        and_CC women_NNS ,_, we_PRP have_VBP suggested_VBN that_IN IDO_NNP plays_VBZ a_DT role_NN in_IN fetal_JJ
        defense_NN against_IN the_DT maternal_NN immune_JJ system_NN and_CC could_MD
        represent_VB a_DT novel_NN means_NNS of_IN immunoregulation_NN ._. The_DT apparently_RB
        diverse_JJ functions_NNS and_CC tissue_NN distribution_NN of_IN IDO_NNP may_MD have_VB
        as_IN a_DT common_JJ theme_NN the_DT fact_NN that_DT tryptophan_NN is_VBZ the_DT rarest_NN
        essential_JJ amino_JJ acid_NN and_CC could_MD be_VB the_DT target_NN for_IN cellular_JJ
        regulatory_JJ mechanisms_NNS ._. If_IN so_RB ,_, tryptophan_NN concentrations_NNS in_IN
        cellular_JJ microenvironments_NNS might_MD play_VB a_DT critical_JJ role_NN in_IN
        modulating_VBG various_JJ cellular_JJ processes_NNS in_IN a_DT way_NN that_DT cannot_NN
        be_VB achieved_VBN by_IN the_DT hepatic_JJ enzyme_NN TDO_NNP which_WDT regulates_VBZ
        systemic_JJ tryptophan_NN concentrations_NNS ._.
        The_DT IDO_NNP promoter_NN contains_VBZ a_DT diverse_JJ collection_NN of_IN motifs_NNS
        together_RB with_IN the_DT IFN-γ_NNP response_NN elements_NNS ._. These_DT include_VBP
        motifs_NNS for_IN transcription_NN factors_NNS that_WDT bind_NN to_TO collagenase_NN
        and_CC elastase_NN genes_NNS and_CC motifs_NNS for_IN the_DT transcription_NN factor_NN
        MEP-_NNP 1_CD ,_, which_WDT regulates_VBZ transcription_NN from_IN the_DT 
        stromelysin-_NN 1_CD (_( MMP-_NNP 3_LS )_) and_CC 
        metallothionein_NN genes_NNS [_NN 18_CD ,_, 19_CD ]_NN ._.
        Matrix_NNP metalloproteinases_NNS (_( MMPs_NNP )_) are_VBP responsible_JJ for_IN
        modification_NN of_IN the_DT extracellular_NN matrix_NN and_CC are_VBP involved_VBN
        in_IN wound_VBD healing_VBG ,_, tumorigenesis_NNS ,_, pregnancy_NN and_CC
        inflammation_NN ._. In_IN general_JJ ,_, they_PRP regulate_VB how_WRB cells_NNS interact_NN
        with_IN each_DT other_JJ and_CC with_IN the_DT extra-cellular_JJ matrix_NN ._.
        Evidence_NN for_IN a_DT tryptophan-reversible_JJ inhibition_NN of_IN MMP_NNP
        expression_NN by_IN IFN-γ_NNP has_VBZ previously_RB been_VBN presented_VBN [_NN 20_CD ,_,
        21_CD ]_NN ,_, although_IN the_DT exact_JJ mechanism_NN is_VBZ unclear_JJ ._. Therefore_RB we_PRP
        decided_VBD to_TO directly_RB test_VB whether_IN IDO_NNP plays_VBZ a_DT role_NN in_IN
        controlling_VBG interactions_NNS with_IN other_JJ cells_NNS and_CC also_RB the_DT
        surrounding_VBG extracellular_NN environment_NN ._.
        We_PRP have_VBP identified_VBN cells_NNS expressing_VBG IDO_NNP 
        in_IN vitro_NN and_CC used_VBN IDO_NNP antisense_NN
        constructs_NNS to_TO inhibit_VB this_DT expression_NN ._. In_IN addition_NN ,_, we_PRP have_VBP
        constitutively_RB overexpressed_JJ IDO_NNP in_IN adherent_NN and_CC
        non-adherent_JJ cell_NN lines_NNS 
        in_IN vitro_NN ._. Our_PRP$ results_NNS demonstrate_VBP
        that_DT tryptophan_NN catabolism_NN has_VBZ significant_JJ effects_NNS on_IN cell_NN
        adhesion_NN and_CC regulates_VBZ the_DT activity_NN and_CC expression_NN of_IN
        cyclooxygenases_NNS 1_CD and_CC 2_CD (_( COX-_NNP 1_CD and_CC -_: 2_LS )_) ._.
      
      
        Results_NNS
        
          Constitutive_NNP overexpression_NN of_IN IDO_NNP alters_NNS cell_NN
          adhesion_NN
          To_TO determine_VB whether_IN IDO_NNP plays_VBZ a_DT role_NN in_IN regulating_VBG
          cell_NN adhesion_NN ,_, we_PRP expressed_VBD a_DT full-length_JJ IDO_NNP cDNA_NN in_IN
          cell_NN lines_NNS 
          in_IN vitro_NN ._. We_PRP transfected_JJ the_DT
          murine_NN macrophage_NN cell_NN line_NN RAW_NNP 264_CD ._. 7_CD with_IN a_DT construct_VB in_IN
          which_WDT IDO_NNP was_VBD expressed_VBN under_IN the_DT control_NN of_IN the_DT murine_NN
          MHC_NNP Class_NNP II_NNP promoter_NN (_( Fig_NNP 1_CD A_DT )_) ._. IDO-transfected_NNP RAW_NNP cell_NN
          clones_NNS ,_, which_WDT expressed_VBD IDO_NNP under_IN the_DT control_NN of_IN the_DT MHC_NNP
          Class_NNP II_NNP promoter_NN ,_, were_VBD characterized_VBN for_IN IDO_NNP expression_NN ._.
          We_PRP selected_VBD four_CD clones_NNS with_IN varying_VBG capacities_NNS for_IN IDO_NNP
          expression_NN and_CC tryptophan_NN depletion_NN from_IN culture_NN medium_NN
          (_( Fig_NNP 1_CD B_NNP ,_, C_NNP ,_, D_NNP ,_, E_NNP )_) ._. Following_VBG 48_CD hours_NNS in_IN culture_NN ,_, clones_NNS 22_CD
          and_CC 11_CD depleted_VBN tryptophan_NN to_TO a_DT greater_JJR extent_NN than_IN
          clones_NNS 6_CD and_CC 8_CD or_CC vector_NN only_RB control_NN ,_, consistent_JJ with_IN
          the_DT greater_JJR vector_NN copy_NN number_NN of_IN these_DT clones_NNS ._. However_RB ,_,
          none_NN of_IN the_DT clones_NNS depleted_VBD a_DT substantial_JJ proportion_NN of_IN
          the_DT tryptophan_NN present_JJ in_IN medium_NN even_RB with_IN longer_JJR
          incubation_NN times_NNS ._. A_DT common_JJ feature_NN of_IN the_DT tryptophan_NN
          depleting_VBG clones_NNS was_VBD their_PRP$ tendency_NN to_TO form_VB macroscopic_JJ
          foci_NN ,_, which_WDT were_VBD visible_JJ to_TO the_DT naked_JJ eye_NN (_( Fig_NNP 2_CD ,_, A_DT ,_, B_NNP ,_, C_NNP )_) ._.
          At_IN a_DT certain_JJ point_NN in_IN focus_NN growth_NN ,_, multicellular_NN
          aggregates_NNS of_IN RAW_NNP cells_NNS would_MD break_VB off_RP from_IN the_DT focus_NN
          and_CC could_MD be_VB seen_VBN floating_VBG in_IN suspension_NN in_IN the_DT tissue_NN
          culture_NN medium_NN ._. Wild_NNP type_NN RAW_NNP cells_NNS or_CC RAW_NNP cells_NNS
          transfected_JJ with_IN vector_NN alone_RB and_CC ,_, to_TO a_DT lesser_JJR extent_NN ,_,
          clones_NNS 6_CD and_CC 8_CD demonstrated_VBD a_DT reduced_VBN ability_NN to_TO form_VB
          macroscopic_JJ foci_NN ._.
          To_TO determine_VB if_IN this_DT phenomenon_NN was_VBD unique_JJ to_TO RAW_NNP
          cells_NNS ,_, we_PRP also_RB transfected_JJ the_DT MC_NNP 57_CD murine_NN fibrosarcoma_NN
          cell_NN line_NN [_NN 22_CD ]_NN which_WDT grows_VBZ as_IN a_DT monolayer_NN ._. MC_NNP 57_CD cells_NNS
          are_VBP fibroblastic_JJ in_IN appearance_NN and_CC disperse_NN across_IN the_DT
          surface_NN of_IN a_DT tissue_NN culture_NN dish_NN in_IN a_DT uniform_NN manner_NN ._.
          Transfection_NNP of_IN a_DT full_JJ length_NN ,_, constitutively_RB expressed_VBD
          IDO_NNP cDNA_NN into_IN MC_NNP 57_CD cells_NNS in_IN the_DT pcDNA_NN 3_CD expression_NN vector_NN ,_,
          resulted_VBD in_IN MC_NNP 57_CD cells_NNS developing_VBG a_DT more_RBR rounded_JJ
          phenotype_NN ._. Furthermore_RB ,_, cells_NNS grew_VBD as_IN multicellular_NN foci_NN ,_,
          in_IN a_DT confined_VBN area_NN ,_, similar_JJ to_TO RAW_NNP cells_NNS ,_, although_IN the_DT
          foci_NN did_VBD not_RB grow_VB to_TO as_IN large_JJ a_DT size_NN before_IN detaching_VBG
          from_IN the_DT plate_NN (_( Fig_NNP 2_CD D_NNP ,_, E_NNP )_) ._. The_DT murine_NN monocytic_JJ cell_NN line_NN
          P_NN 388_CD was_VBD also_RB transfected_JJ and_CC expressed_VBD IDO_NNP ._. It_PRP likewise_RB
          exhibited_VBN a_DT change_NN in_IN morphology_NN similar_JJ to_TO that_DT
          described_VBD above_IN and_CC clones_NNS expressing_VBG IDO_NNP often_RB changed_VBD
          from_IN non-attached_JJ suspension_NN cultures_NNS to_TO adherent_NN
          cultures_NNS which_WDT resembled_JJ RAW_NNP cells_NNS (_( not_RB shown_VBN )_) ._.
          IDO-expressing_NNP clones_NNS were_VBD also_RB slower_JJR to_TO re-attach_JJ to_TO
          tissue_NN culture_NN dishes_NNS following_VBG sub-culture_JJ and_CC could_MD be_VB
          seen_VBN floating_VBG as_IN multicellular_NN aggregates_NNS ._. To_TO quantitate_NN
          the_DT change_NN in_IN cell_NN adhesion_NN in_IN IDO-transfected_NNP RAW_NNP cells_NNS ,_,
          we_PRP performed_VBD binding_JJ studies_NNS to_TO tissue_NN culture_NN plates_NNS
          coated_VBN with_IN various_JJ extra-cellular_JJ matrices_NNS ,_, including_VBG
          collagen_NN ,_, laminin_NN ,_, matrigel_NN ,_, and_CC fibronectin_NN ._. Neither_DT
          vector-only_JJ controls_NNS nor_CC IDO-expressing_NNP cells_NNS adhered_VBD
          significantly_RB to_TO laminin_NN or_CC matrigel_NN coated_JJ plates_NNS in_IN a_DT
          45_CD minute_NN assay_NN period_NN (_( not_RB shown_VBN )_) and_CC both_DT controls_NNS and_CC
          IDO-expressing_NNP cells_NNS adhered_VBD strongly_RB and_CC to_TO similar_JJ
          extents_NNS to_TO fibronectin_NN coated_JJ plates_NNS (_( Fig_NNP 3_CD A_DT )_) ._. However_RB ,_,
          there_EX was_VBD a_DT substantial_JJ difference_NN in_IN adhesion_NN to_TO
          collagen-coated_JJ plates_NNS ._. Although_IN neither_DT sample_NN adhered_VBD
          to_TO collagen_NN to_TO the_DT same_JJ extent_NN as_IN to_TO fibronectin_NN ,_, vector_NN
          only_RB controls_VBZ adhered_VBD more_RBR strongly_RB than_IN IDO-expressing_NNP
          clone_NN 11_CD (_( Fig_NNP 3_CD B_NNP )_) ._.
        
        
          IDO_NNP expression_NN is_VBZ induced_VBN during_IN cell_NN attachment_NN to_TO
          growth_VB substrates_NNS
          To_TO determine_VB if_IN IDO_NNP normally_RB plays_VBZ a_DT role_NN during_IN the_DT
          course_NN of_IN cell_NN adhesion_NN ,_, we_PRP detached_VBN log_VB phase_NN ,_, wild_JJ type_NN
          RAW_NNP cells_NNS from_IN their_PRP$ culture_NN flasks_NNS by_IN scraping_VBG ,_, reseeded_JJ
          them_PRP into_IN fresh_JJ medium_NN and_CC assayed_JJ for_IN IDO_NNP expression_NN at_IN
          subsequent_JJ time_NN points_NNS ._. Log_NNP phase_NN cells_NNS do_VBP not_RB express_VB
          IDO_NNP at_IN levels_NNS detectable_JJ by_IN standard_JJ RT-PCR_NNP methods_NNS ._.
          However_RB ,_, in_IN cells_NNS detached_VBN from_IN their_PRP$ normal_JJ growth_NN
          substrate_NN ,_, IDO_NNP expression_NN was_VBD already_RB induced_VBN by_IN 5_CD hours_NNS
          following_VBG reseeding_VBG into_IN fresh_JJ tissue_NN culture_NN dishes_NNS and_CC
          expression_NN was_VBD detected_VBN until_IN 48_CD hours_NNS (_( Fig_NNP 4_CD A_DT )_) ._. Onset_NNP of_IN
          expression_NN coincided_VBD with_IN the_DT time_NN when_WRB the_DT majority_NN of_IN
          cells_NNS had_VBD begun_VBN to_TO adhere_VB to_TO the_DT plate_NN ._.
          To_TO determine_VB if_IN IDO_NNP expression_NN was_VBD restricted_VBN to_TO cell_NN
          interactions_NNS with_IN standard_JJ tissue_NN culture_NN substrates_NNS and_CC
          to_TO further_VB explore_VB the_DT possibility_NN that_IN IDO_NNP altered_VBD
          inter-cellular_JJ adhesiveness_NNS ,_, we_PRP studied_VBD the_DT murine_NN
          embryonic_JJ carcinoma_NN cell_NN line_NN P_NN 19_CD ._. This_DT cell_NN has_VBZ been_VBN
          characterized_VBN extensively_RB and_CC differentiates_NNS into_IN
          skeletal_NN and_CC cardiac_JJ muscle_NN or_CC neuronal_NN cells_NNS ,_, depending_VBG
          on_IN whether_IN it_PRP is_VBZ treated_VBN with_IN DMSO_NNP or_CC retinoic_JJ acid_NN (_( RA_NNP )_)
          respectively_RB [_NN 23_CD ,_, 24_CD ,_, 25_CD ]_NN ._. Differentiation_NNP is_VBZ dependent_JJ
          on_IN an_DT initial_NN ,_, 3_CD -_: 5_CD day_NN incubation_NN as_IN multicellular_NN
          aggregates_NNS in_IN suspension_NN culture_NN ,_, in_IN the_DT presence_NN of_IN
          drug_NN ,_, followed_VBN by_IN a_DT similar_JJ period_NN growing_VBG as_IN monolayer_NN
          adherent_NN cells_NNS in_IN the_DT absence_NN of_IN drug_NN ._. Mature_NNP
          differentiated_JJ cells_NNS begin_VBP to_TO appear_VB during_IN this_DT
          subsequent_JJ growth_NN period_NN in_IN the_DT absence_NN of_IN drug_NN ._.
          IDO_NNP expression_NN was_VBD detected_VBN when_WRB P_NN 19_CD cells_NNS were_VBD
          reseeded_JJ into_IN bacterial_JJ petri_NN dishes_NNS as_IN suspension_NN
          cultures_NNS and_CC allowed_VBN to_TO form_VB aggregates_NNS ._. IDO_NNP expression_NN
          was_VBD observed_VBN within_IN 12_CD hours_NNS of_IN seeding_VBG into_IN suspension_NN
          with_IN DMSO_NNP and_CC peaked_VBD around_IN 48_CD -_: 54_CD hours_NNS ._. (_( Fig_NNP 4_CD B_NNP )_) ._. Thus_RB ,_,
          removing_VBG cells_NNS from_IN their_PRP$ normal_JJ growth_NN substrate_NN and_CC
          reseeding_VBG into_IN fresh_JJ medium_NN induced_VBD a_DT burst_NN of_IN IDO_NNP
          expression_NN irrespective_RB of_IN whether_IN cells_NNS reassociated_JJ
          with_IN tissue_NN culture_NN substrate_NN or_CC other_JJ cells_NNS ._. Aggregating_NNP
          cells_NNS in_IN the_DT presence_NN of_IN 10_CD -_: 6_CD M_NNP RA_NNP ,_, which_WDT induces_VBZ
          neuronal_NN differentiation_NN also_RB induced_VBD a_DT transient_JJ burst_NN
          of_IN IDO_NNP transcription_NN but_CC the_DT period_NN was_VBD shorter_JJR and_CC the_DT
          peak_NN level_NN observed_VBD was_VBD lower_JJR than_IN that_DT observed_VBD with_IN
          DMSO_NNP ._.
          To_TO determine_VB if_IN IDO_NNP expression_NN was_VBD related_VBN to_TO the_DT
          removal_NN of_IN cells_NNS from_IN their_PRP$ normal_JJ growth_NN substrate_NN or_CC
          the_DT process_NN of_IN reattachment_NN to_TO new_JJ substrate_NN ,_, we_PRP
          trypsinized_JJ P_NN 19_CD cells_NNS and_CC reseeded_JJ them_PRP as_IN aggregates_NNS in_IN
          suspension_NN in_IN the_DT presence_NN of_IN various_JJ concentrations_NNS of_IN
          EGTA_NNP ._. EGTA_NNP chelates_NNS essential_JJ Ca_MD 2_CD +_NN required_VBN by_IN cadherin_NN
          molecules_NNS and_CC inhibits_NNS cell_NN adhesion_NN ._. We_PRP observed_VBD a_DT
          concentration_NN dependent_JJ decrease_NN in_IN IDO_NNP expression_NN in_IN
          EGTA_NNP treated_VBD samples_NNS 24_CD hours_NNS after_IN seeding_VBG ,_, which_WDT
          paralleled_JJ a_DT corresponding_JJ decrease_NN in_IN cell_NN aggregation_NN
          (_( Fig_NNP 4_CD C_NNP )_) ._. Therefore_RB ,_, IDO_NNP expression_NN appeared_VBD to_TO be_VB
          induced_VBN by_IN reattachment_NN ,_, rather_RB than_IN detachment_NN from_IN a_DT
          previous_JJ substrate_NN ._. Thus_RB ,_, IDO_NNP is_VBZ thus_RB expressed_VBN
          endogenously_RB in_IN various_JJ cell_NN types_NNS and_CC is_VBZ induced_VBN during_IN
          cell_NN attachment_NN to_TO growth_VB substrates_NNS ._.
        
        
          Inhibition_NNP of_IN endogenous_JJ IDO_NNP expression_NN disrupts_NNS
          P_NN 19_CD cell_NN adhesion_NN
          To_TO examine_VB the_DT role_NN of_IN IDO_NNP expression_NN in_IN P_NN 19_CD cells_NNS ,_, we_PRP
          transfected_JJ P_NN 19_CD cells_NNS with_IN a_DT DNA_NNP construct_VB which_WDT
          contained_VBD a_DT 740_CD bp_NN fragment_NN of_IN murine_NN IDO_NNP cDNA_NN in_IN the_DT
          antisense_NN orientation_NN ,_, under_IN the_DT control_NN of_IN the_DT
          constitutively_RB active_JJ CMV_NNP promoter_NN in_IN the_DT pcDNA-_NN 3_CD
          mammalian_JJ expression_NN vector_NN ._. As_IN control_NN ,_, the_DT IDO_NNP gene_NN
          fragment_NN was_VBD cloned_VBN in_IN a_DT sense_NN orientation_NN ._. To_TO confirm_VB
          that_IN transfected_JJ ,_, G_NNP 418_CD resistant_JJ P_NN 19_CD cells_NNS expressed_VBD IDO_NNP
          antisense_NN transcripts_NNS ,_, we_PRP isolated_VBD total_JJ RNA_NNP from_IN G_NNP 418_CD
          resistant_JJ clones_NNS ,_, reverse_VB transcribed_JJ it_PRP into_IN cDNA_NN using_VBG
          a_DT sense_NN primer_NN then_RB PCR_NNP amplified_VBN the_DT cDNA_NN ._. Three_CD
          antisense-transfected_JJ clones_NNS ,_, which_WDT expressed_VBD
          progressively_RB greater_JJR amounts_NNS of_IN IDO_NNP antisense_NN RNA_NNP were_VBD
          selected_VBN for_IN further_JJ analysis_NN together_RB with_IN a_DT sense_NN
          control_NN (_( Fig_NNP 4_CD D_NNP )_) ._. The_DT ability_NN of_IN the_DT sense_NN and_CC antisense_NN
          transfectants_NNS to_TO deplete_VB tryptophan_NN from_IN culture_NN medium_NN
          was_VBD determined_VBN following_VBG 48_CD hours_NNS in_IN culture_NN ._. IDO_NNP sense_NN
          transfected_JJ P_NN 19_CD cells_NNS depleted_VBD 10_CD %_NN of_IN available_JJ culture_NN
          tryptophan_NN (_( not_RB shown_VBN )_) while_IN IDO_NNP antisense_NN transfected_JJ
          P_NN 19_CD clones_NNS which_WDT expressed_VBD high_JJ levels_NNS of_IN antisense_NN
          (_( clones_NNS D_NNP 3_CD and_CC E_NNP 6_CD )_) depleted_VBN essentially_RB no_DT tryptophan_NN
          from_IN the_DT medium_NN ._. Clone_NNP C_NNP 2_CD ,_, which_WDT expressed_VBD low_JJ levels_NNS of_IN
          IDO_NNP antisense_NN ,_, depleted_VBD similar_JJ levels_NNS of_IN tryptophan_NN to_TO
          the_DT sense_NN control_NN ._. Therefore_RB ,_, the_DT burst_NN of_IN IDO_NNP
          expression_NN ,_, which_WDT takes_VBZ place_NN in_IN cells_NNS during_IN
          reattachment_NN does_VBZ not_RB result_VB in_IN substantial_JJ tryptophan_NN
          depletion_NN from_IN culture_NN medium_NN
          IDO_NNP antisense-transfected_JJ clones_NNS D_NNP 3_CD and_CC E_NNP 6_CD exhibited_VBN a_DT
          different_JJ phenotype_NN compared_VBN to_TO untransfected_JJ and_CC sense_VB
          transfected_JJ P_NN 19_CD cells_NNS (_( Fig_NNP 5_CD A_DT ,_, B_NNP ,_, C_NNP )_) ._. IDO_NNP antisense_NN
          expressing_VBG clones_NNS developed_VBD a_DT rounded_VBN appearance_NN with_IN a_DT
          more_RBR scattered_JJ morphology_NN and_CC apparent_JJ loss_NN of_IN cell_NN
          interaction_NN instead_RB of_IN the_DT usual_JJ ,_, adherent_NN P_NN 19_CD phenotype_NN ._.
          The_DT degree_NN to_TO which_WDT this_DT phenotype_NN manifested_JJ ,_, correlated_JJ
          with_IN the_DT extent_NN of_IN IDO_NNP antisense_NN expression_NN ,_, i_NNP ._. e_SYM ._. it_PRP was_VBD
          prominent_JJ in_IN clone_NN E_NNP 6_CD and_CC D_NNP 3_CD while_IN clone_NN C_NNP 2_CD was_VBD
          indistinguishable_JJ from_IN sense-transfected_JJ controls_NNS ._.
          However_RB growth_NN rates_NNS were_VBD largely_RB unaltered_JJ ._.
          IDO-antisense_NNP and_CC sense_NN transfectants_NNS were_VBD aggregated_JJ in_IN
          1_CD %_NN DMSO_NNP and_CC cell_NN aggregates_NNS were_VBD visualized_JJ by_IN phase_NN
          contrast_NN microscopy_NN ._. Sense_NN or_CC untransfected_JJ P_NN 19_CD cells_NNS
          aggregated_JJ normally_RB as_RB tightly_RB packed_VBN spheroid_NN bodies_NNS ._. In_IN
          contrast_NN ,_, antisense_NN transfectants_NNS formed_VBD aggregates_NNS ,_,
          which_WDT exhibited_VBN markedly_RB different_JJ morphologies_NNS and_CC
          differed_VBD from_IN sense-transfected_JJ aggregates_NNS in_IN two_CD
          principal_JJ respects_VBZ ;_: shape_NN and_CC size_NN (_( Fig_NNP 5_CD D_NNP ,_, E_NNP ,_, F_NN )_) ._. At_IN 30_CD
          hours_NNS after_IN seeding_VBG suspension_NN cultures_NNS ,_, cells_NNS formed_VBD
          irregular_JJ shaped_VBN ,_, non-spherical_JJ aggregates_NNS that_WDT were_VBD less_RBR
          tightly_RB packed_VBN than_IN control_NN aggregates_NNS ._. Antisense_NNP clone_NN
          E_NNP 6_CD (_( shown_VBN in_IN Fig_NNP ._. 5_LS F_NN )_) produced_VBN aggregates_NNS which_WDT were_VBD only_RB
          loosely_RB packed_VBN and_CC a_DT substantial_JJ number_NN of_IN cells_NNS which_WDT
          did_VBD not_RB package_VB into_IN any_DT form_NN of_IN aggregate_JJ while_IN
          antisense_NN clone_NN D_NNP 3_CD formed_VBN aggregates_NNS more_RBR diverse_JJ in_IN
          shape_NN than_IN the_DT uniformly_RB spherical_JJ controls_NNS but_CC less_RBR
          diverse_JJ than_IN clone_NN E_NNP 6_CD ._. Clone_NNP C_NNP 2_CD produced_VBN aggregates_NNS
          similar_JJ to_TO sense_VB transfected_JJ controls_NNS (_( not_RB shown_VBN )_) ._.
          To_TO quantitate_NN and_CC compare_VB the_DT size_NN difference_NN between_IN
          sense_NN and_CC antisense-transfected_JJ aggregates_NNS we_PRP
          photographed_VBN sense_NN and_CC antisense_NN clone_NN 5_CD aggregates_NNS and_CC
          calculated_VBD the_DT area_NN of_IN each_DT aggregate_NN individually_RB (_( Fig_NNP ._.
          5_LS G_NNP )_) ._. Antisense_NNP aggregates_NNS were_VBD small_JJ ,_, predominantly_RB in_IN
          the_DT 0_CD ._. 2_CD -_: 0_CD ._. 4_LS sq_NN ._. inch_NN size_NN range_NN ,_, whereas_IN control_NN
          aggregate_JJ sizes_NNS were_VBD spread_VBN over_IN a_DT much_RB broader_JJR range_NN ._.
          The_DT mean_JJ size_NN of_IN antisense-transfected_JJ aggregates_NNS was_VBD
          0_CD ._. 31_CD sq_NN ._. inches_NNS ,_, while_IN sense_NN transfected_JJ controls_NNS had_VBD a_DT
          mean_NN of_IN 0_CD ._. 69_CD sq_NN ._. inches_NNS (_( p_NN <_NN 0_CD ._. 0001_CD )_) ._. The_DT effect_NN of_IN
          IDO_NNP inhibition_NN on_IN cell_NN adhesion_NN was_VBD demonstrated_VBN by_IN
          performing_VBG cell_NN migration_NN assays_NNS ._. P_NN 19_CD cells_NNS were_VBD seeded_VBN
          into_IN porous_JJ tissue_NN culture_NN inserts_NNS placed_VBN in_IN a_DT 24_CD well_RB
          tissue_NN culture_NN plate_NN and_CC cell_NN migration_NN to_TO the_DT lower_JJR
          chamber_NN in_IN the_DT absence_NN of_IN any_DT stimulus_NN was_VBD determined_VBN ._.
          Approximately_RB 12_CD %_NN of_IN clone_NN E_NNP 6_CD cells_NNS migrated_JJ to_TO the_DT lower_JJR
          chamber_NN 18_CD hours_NNS after_IN seeding_VBG into_IN the_DT upper_JJ chamber_NN
          (_( Fig_NNP ._. 5_LS H_NNP )_) ._. In_IN contrast_NN ,_, less_JJR than_IN 1_CD %_NN of_IN control_NN cells_NNS had_VBD
          migrated_JJ in_IN the_DT same_JJ period_NN ._. Clones_NNP C_NNP 2_CD and_CC D_NNP 3_CD produced_VBN
          intermediate_JJ levels_NNS of_IN migration_NN ._. When_WRB inserts_NNS were_VBD
          coated_VBN with_IN Matrigel_NNP ,_, no_DT significant_JJ migration_NN was_VBD seen_VBN
          in_IN either_DT antisense_NN or_CC sense_NN transfectants_NNS ,_, indicating_VBG
          that_DT cell_NN motility_NN could_MD be_VB inhibited_VBD by_IN supplying_VBG an_DT
          extracellular_NN matrix_NN ._.
        
        
          IDO_NNP axpression_NN alters_NNS metalloproteinase_NN
          expression_NN
          The_DT altered_VBN adhesion_NN of_IN IDO-expressing_NNP RAW_NNP cells_NNS to_TO
          collagen_NN suggested_VBD that_IN IDO_NNP might_MD induce_VB alterations_NNS in_IN
          enzymes_NNS involved_VBN in_IN modifying_VBG the_DT extracellular_NN matrix_NN ._.
          Therefore_RB ,_, we_PRP investigated_VBD whether_IN inhibition_NN of_IN IDO_NNP
          expression_NN in_IN the_DT P_NN 19_CD 
          in_IN vitro_NN aggregation_NN system_NN and_CC the_DT
          constitutive_JJ overexpression_NN of_IN IDO_NNP in_IN RAW_NNP cells_NNS had_VBD any_DT
          effect_NN on_IN MMP_NNP expression_NN ._. We_PRP allowed_VBD the_DT sense_NN and_CC
          three-antisense_JJ expressing_VBG clones_NNS of_IN P_NN 19_CD to_TO aggregate_JJ in_IN
          1_CD %_NN ._. DMSO_NNP for_IN 24_CD hours_NNS ,_, before_IN harvesting_NN total_JJ RNA_NNP and_CC
          determining_VBG expression_NN of_IN various_JJ MMP_NNP genes_NNS ,_, including_VBG 
          stromelysins_NNS 1_CD (_( MMP-_NNP 3_LS )_) ,_, 
          2_CD (_( MMP-_NNP 10_CD )_) and_CC 
          3_CD (_( MMP-_NNP 11_CD )_) ,_, 
          collagenases_NNS I_PRP (_( MMP-_NNP 1_LS )_) and_CC 
          IV_NNP (_( MMP-_NNP 2_LS )_) and_CC 
          meltrins_NNS α_NN (_( ADAM-_NNP 12_CD )_) and_CC β_NN
          (_( ADAM-_NNP 19_CD )_) ._. 
          Meltrin_NNP α_NN is_VBZ expressed_VBN 
          in_IN vivo_NN during_IN development_NN in_IN
          condensed_JJ mesenchymal_NN cells_NNS that_WDT give_VBP rise_NN to_TO skeletal_NN
          muscle_NN while_IN meltrin_NN β_NN is_VBZ expressed_VBN in_IN craniofacial_NN and_CC
          dorsal_NN root_NN ganglia_NN where_WRB neuronal_NN lineages_NNS differentiate_VB
          [_NN 26_CD ]_NN ._. Expression_NNP of_IN 
          stromelysin_NN s-_NN 
          1_CD and_CC 
          3_CD and_CC 
          meltrin_NN α_NN ,_, was_VBD increased_VBN in_IN
          antisense-expressing_JJ aggregates_NNS ,_, relative_JJ to_TO the_DT sense_NN
          control_NN (_( Fig_NNP 6_CD A_DT )_) ._. Furthermore_RB ,_, there_EX was_VBD a_DT progressive_JJ
          increase_NN in_IN the_DT expression_NN level_NN of_IN these_DT three_CD protease_NN
          genes_NNS ,_, which_WDT correlated_JJ with_IN the_DT amount_NN of_IN IDO_NNP antisense_NN
          expression_NN ._. In_IN contrast_NN ,_, the_DT expression_NN of_IN 
          meltri_NN n-β_JJ and_CC 
          stromelysi_NN n-_NN 
          2_CD was_VBD similar_JJ in_IN all_DT samples_NNS and_CC
          expression_NN of_IN 
          collagenase_NN I_PRP or_CC 
          IV_NNP was_VBD undetectable_JJ in_IN either_DT sense_NN
          or_CC antisense-expressing_JJ aggregates_NNS (_( not_RB shown_VBN )_) ._. Thus_RB ,_,
          inhibition_NN of_IN IDO_NNP gene_NN expression_NN correlated_JJ with_IN
          increased_VBN expression_NN of_IN some_DT but_CC not_RB all_DT MMP_NNP genes_NNS in_IN P_NN 19_CD
          cells_NNS undergoing_VBG aggregation_NN ._. Furthermore_RB ,_, increased_VBD MMP_NNP
          expression_NN coincided_VBD with_IN decreased_VBD ability_NN of_IN P_NN 19_CD cells_NNS
          to_TO aggregate_JJ in_IN suspension_NN culture_NN ._. To_TO determine_VB whether_IN
          IDO-expressing_NNP RAW_NNP cells_NNS also_RB showed_VBD unusual_JJ MMP_NNP
          expression_NN we_PRP tested_VBD the_DT IDO-expressing_NNP RAW_NNP cell_NN clones_NNS
          for_IN the_DT same_JJ group_NN of_IN MMPs_NNP as_IN P_NN 19_CD cells_NNS ._. Expression_NNP of_IN
          all_DT MMPs_NNP was_VBD undetectable_JJ except_IN for_IN collagenase_NN I_PRP ._. This_DT
          showed_VBD significant_JJ expression_NN in_IN vector-only_JJ controls_NNS but_CC
          little_JJ or_CC no_DT expression_NN in_IN IDO-expressing_NNP clones_NNS ._. All_DT
          IDO-expressing_NNP clones_NNS demonstrated_VBN reduced_VBN expression_NN
          with_IN no_DT correlation_NN to_TO the_DT level_NN of_IN IDO_NNP expression_NN (_( Fig_NNP
          6_CD B_NNP )_) ._. Pharmacological_NNP inhibition_NN of_IN MMP_NNP activity_NN in_IN P_NN 19_CD
          cells_NNS using_VBG the_DT broad_JJ spectrum_NN ,_, hydroxamic_JJ acid-based_JJ MMP_NNP
          inhibitor_NN GM_NNP 6001_CD at_IN concentrations_NNS ranging_VBG from_IN 1_CD -_: 30_CD μM_NN ,_,
          resulted_VBD in_IN partial_JJ reversal_NN of_IN the_DT poor_JJ aggregation_NN
          shown_VBN by_IN IDO-AS_NNP expressing_VBG cells_NNS ,_, with_IN a_DT maximal_NN effect_NN
          shown_VBN at_IN 20_CD μM_NN ,_, indicating_VBG that_IN changes_NNS in_IN MMP_NNP expression_NN
          were_VBD responsible_JJ ,_, at_IN least_JJS in_IN part_NN for_IN altered_VBN cell_NN
          adhesion_NN ._.
        
        
          IDO_NNP regulates_VBZ prostaglandin_NN synthesis_NN
          To_TO understand_VB the_DT mechanism_NN of_IN IDO_NNP induced_VBD alterations_NNS
          in_IN cell_NN adhesion_NN and_CC MMP_NNP expression_NN ,_, we_PRP attempted_VBD to_TO
          reverse_VB IDO_NNP effects_NNS on_IN cell_NN adhesion_NN ._. As_IN previously_RB
          mentioned_VBN ,_, tryptophan_NN is_VBZ not_RB significantly_RB depleted_VBN in_IN
          culture_NN medium_NN of_IN RAW_NNP cells_NNS overexpressing_VBG IDO_NNP ,_,
          suggesting_VBG that_DT tryptophan_NN deprivation_NN is_VBZ not_RB the_DT cause_NN
          of_IN the_DT IDO_NNP effect_NN ._. Consistent_NNP with_IN this_DT ,_, adding_VBG back_RB
          tryptophan_NN to_TO IDO-expressing_NNP RAW_NNP cells_NNS did_VBD not_RB reverse_VB
          the_DT growth_NN of_IN macroscopic_JJ foci_NN ._. As_IN tryptophan_NN is_VBZ not_RB the_DT
          only_JJ substrate_NN for_IN IDO_NNP ,_, we_PRP also_RB investigated_VBD whether_IN
          adding_VBG serotonin_NN would_MD overcome_VB the_DT effects_NNS of_IN IDO_NNP
          expression_NN ._. There_EX was_VBD a_DT similar_JJ lack_NN of_IN effect_NN of_IN this_DT
          compound_NN ._. This_DT suggested_VBD that_DT depletion_NN or_CC reduction_NN of_IN
          an_DT IDO_NNP substrate_NN was_VBD probably_RB not_RB responsible_JJ for_IN the_DT
          effects_NNS described_VBD here_RB ._. An_DT alternative_JJ possibility_NN was_VBD
          that_IN a_DT biologically_RB active_JJ downstream_JJ catabolite_NN of_IN IDO_NNP
          could_MD be_VB the_DT cause_NN ._. Therefore_RB ,_, we_PRP tested_VBD the_DT tryptophan_NN
          catabolites_NNS ,_, picolinic_JJ acid_NN and_CC quinolinic_JJ acid_NN to_TO see_VB if_IN
          they_PRP could_MD reproduce_VB the_DT effects_NNS of_IN IDO_NNP overexpression_NN ._.
          Picolinic_NNP acid_NN (_( 1_CD -_: 6_CD mM_NN )_) produced_VBN morphological_JJ changes_NNS in_IN
          both_DT MC_NNP 57_CD and_CC RAW_NNP cells_NNS and_CC also_RB substantial_JJ reductions_NNS
          in_IN growth_NN rate_NN but_CC did_VBD not_RB mimic_VB the_DT effects_NNS of_IN IDO_NNP
          expression_NN ._. In_IN particular_JJ ,_, at_IN a_DT concentration_NN of_IN 2_CD mM_NN ,_,
          picolinic_JJ acid_NN induced_VBD a_DT more_RBR flattened_VBN phenotype_NN ._. At_IN
          concentrations_NNS above_IN 6_CD mM_NN ,_, picolinic_JJ acid-induced_JJ
          apoptosis_NNS was_VBD observed_VBN ._. Quinolinic_NNP acid_NN was_VBD essentially_RB
          without_IN effect_NN at_IN concentrations_NNS up_IN to_TO 10_CD mM_NN ._. Therefore_RB ,_,
          the_DT exact_JJ mode_NN of_IN action_NN of_IN IDO_NNP therefore_RB remains_VBZ to_TO be_VB
          determined_VBN ._.
          Despite_IN the_DT uncertainty_NN about_IN the_DT proximal_NN mediator_NN of_IN
          IDO_NNP 's_POS effect_NN ,_, it_PRP is_VBZ known_VBN that_IN alterations_NNS in_IN cell_NN
          adhesion_NN and_CC metalloproteinase_NN activity_NN are_VBP often_RB
          associated_VBN with_IN changes_NNS in_IN prostaglandin_NN synthesis_NN [_NN 27_CD ,_,
          28_CD ,_, 29_CD ,_, 30_CD ]_NN ._. Therefore_RB ,_, we_PRP analyzed_VBD the_DT spectrum_NN of_IN PGs_NNP
          produced_VBN by_IN IDO-expressing_NNP RAW_NNP cells_NNS using_VBG thin_JJ layer_NN
          chromatography_NN ._. PG_NNP D_NNP 
          2_CD was_VBD the_DT major_JJ product_NN of_IN both_DT
          vector-only_JJ controls_NNS and_CC IDO-expressing_NNP clone_NN 11_CD ,_,
          consistent_JJ with_IN reports_NNS that_IN D_NNP 
          2_CD production_NN is_VBZ typical_JJ of_IN
          antigen-presenting_JJ cells_NNS [_NN 31_CD ]_NN ._. There_EX was_VBD a_DT greater_JJR than_IN
          50_CD %_NN reduction_NN in_IN PG_NNP D_NNP 
          2_CD production_NN in_IN clone_NN 11_CD compared_VBN with_IN
          the_DT vector_NN only_RB control_NN and_CC a_DT similar_JJ decrease_NN in_IN levels_NNS
          of_IN PGs_NNP F_NNP 
          2_CD α_NN ,_, 6_CD keto-_NN F_NN 
          1_CD α_NN and_CC thromboxane_NN B_NNP 
          2_CD in_IN this_DT clone_NN (_( Fig_NNP 7_CD A_DT )_) ._. However_RB ,_, PG_NNP
          E_NNP 
          2_CD production_NN was_VBD affected_VBN relatively_RB
          little_JJ compared_VBN to_TO the_DT other_JJ PGs_NNP ._. Thus_RB IDO_NNP overexpression_NN
          resulted_VBD in_IN an_DT increase_NN in_IN PG_NNP E_NNP 
          2_CD relative_JJ to_TO the_DT other_JJ PGs_NNP ._. However_RB ,_,
          in_IN MC_NNP 57_CD cells_NNS ,_, the_DT prostaglandin_NN profile_NN was_VBD quite_RB
          different_JJ from_IN that_DT seen_VBN in_IN RAW_NNP cells_NNS ._. PG_NNP E_NNP 
          2_CD was_VBD the_DT dominant_JJ prostaglandin_NN (_( Fig_NNP
          7_CD B_NNP )_) and_CC overexpression_NN of_IN IDO_NNP resulted_VBD in_IN a_DT relative_JJ
          increase_NN in_IN the_DT amount_NN of_IN PG_NNP D_NNP 
          2_CD and_CC other_JJ PGs_NNP ,_, relative_JJ to_TO E_NNP 
          2_CD ._.
          In_IN IDO-expressing_NNP RAW_NNP cells_NNS ,_, COX-_NNP 1_CD protein_NN levels_NNS were_VBD
          unchanged_JJ compared_VBN to_TO the_DT vector-only_JJ control_NN (_( Fig_NNP 8_CD A_DT )_) ._.
          In_IN contrast_NN ,_, COX-_NNP 2_CD was_VBD not_RB expressed_VBN by_IN vector_NN only_RB
          controls_VBZ or_CC RAW_NNP clones_NNS 6_CD ,_, 8_CD and_CC 22_CD but_CC COX-_NNP 2_CD mRNA_NN and_CC
          protein_NN was_VBD induced_VBN in_IN the_DT RAW_NNP clone_NN expressing_VBG the_DT
          greatest_JJS amount_NN of_IN IDO_NNP (_( clone_NN 11_CD )_) (_( Fig_NNP 8_CD A_DT )_) ._. Although_IN
          COX-_NNP 2_CD is_VBZ not_RB usually_RB expressed_VBD in_IN RAW_NNP cells_NNS ,_, it_PRP can_MD be_VB
          strongly_RB induced_VBN with_IN lipopolysaccharide_NN (_( LPS_NNP )_) [_NN 32_CD ,_, 33_CD ]_NN ._.
          Therefore_RB ,_, we_PRP treated_VBD IDO_NNP transfected_JJ RAW_NNP cells_NNS and_CC
          controls_NNS with_IN LPS_NNP and_CC measured_VBN COX-_NNP 2_CD expression_NN 24_CD hours_NNS
          later_RB ._. COX-_NNP 2_CD mRNA_NN was_VBD most_RBS strongly_RB induced_VBN in_IN vector_NN
          only_RB or_CC low_JJ IDO-expressing_NNP clones_NNS (_( Fig_NNP 8_CD B_NNP )_) ._. Curiously_RB ,_,
          clones_NNS expressing_VBG higher_JJR levels_NNS of_IN IDO_NNP (_( clones_NNS 22_CD and_CC 11_CD )_)
          showed_VBD lower_JJR levels_NNS of_IN COX-_NNP 2_CD mRNA_NN induction_NN ._. In_IN contrast_NN ,_,
          COX-_NNP 2_CD protein_NN levels_NNS were_VBD higher_JJR in_IN clones_NNS expressing_VBG
          lower_JJR amounts_NNS of_IN IDO_NNP mRNA_NN and_CC lower_JJR in_IN vector_NN only_RB
          controls_VBZ ,_, whereas_IN COX-_NNP 1_CD protein_NN levels_NNS were_VBD unchanged_JJ by_IN
          LPS_NNP treatment_NN ._. MC_NNP 57_CD cells_NNS expressed_VBD COX-_NNP 2_CD constitutively_RB ,_,
          consistent_JJ with_IN the_DT domination_NN of_IN the_DT PG_NNP profile_NN by_IN PG_NNP E_NNP 
          2_CD ._. However_RB ,_, IDO_NNP overexpressing_VBG clone_NN
          26_CD showed_VBD a_DT reduced_VBN amount_NN of_IN COX-_NNP 2_CD protein_NN compared_VBN to_TO
          the_DT vector_NN only_RB control_NN (_( Fig_NNP 8_CD C_NNP )_) ._.
          If_IN uniformly_RB diminished_VBN PG_NNP synthesis_NN by_IN IDO_NNP was_VBD
          responsible_JJ for_IN growth_NN of_IN RAW_NNP cell_NN macroscopic_JJ foci_NN ,_,
          inhibiting_VBG PG_NNP synthesis_NN with_IN a_DT pharmacological_JJ inhibitor_NN
          of_IN COX-_NNP 1_CD and_CC -_: 2_CD ought_MD to_TO reproduce_VB the_DT effect_NN of_IN IDO_NNP
          expression_NN ._. Therefore_RB we_PRP treated_VBD vector-only_JJ transfected_JJ
          RAW_NNP cells_NNS with_IN various_JJ concentrations_NNS of_IN indomethacin_NN
          ranging_VBG from_IN 0_CD ._. 1_CD μM_NN to_TO 100_CD mM_NN ._. Although_IN some_DT effect_NN of_IN
          indomethacin_NN on_IN cell_NN growth_NN rate_NN was_VBD observed_VBN ,_, there_EX was_VBD
          no_DT sign_NN of_IN macroscopic_JJ foci_NN (_( data_NNS not_RB shown_VBN )_) ._. Thus_RB IDO_NNP
          expression_NN does_VBZ not_RB mimic_VB the_DT effects_NNS of_IN a_DT global_JJ COX_NNP
          inhibitor_NN ._. To_TO test_VB the_DT hypothesis_NNS that_IN alterations_NNS in_IN the_DT
          relative_JJ levels_NNS of_IN PGs_NNP were_VBD responsible_JJ for_IN the_DT growth_NN of_IN
          macroscopic_JJ foci_NN ,_, we_PRP added_VBD PGs_NNP directly_RB to_TO vector-only_JJ
          transfected_JJ RAW_NNP cells_NNS ._. The_DT phenotype_NN produced_VBN by_IN IDO_NNP
          expression_NN could_MD be_VB reproduced_VBD by_IN adding_VBG PG_NNP E_NNP 
          2_CD alone_RB to_TO the_DT cultures_NNS ._. PG_NNP E_NNP 
          2_CD addition_NN resulted_VBD in_IN a_DT
          dose-dependent_JJ increase_NN in_IN the_DT appearance_NN of_IN macroscopic_JJ
          foci_NN ,_, with_IN visible_JJ foci_NN appearing_VBG at_IN 1_CD ng_NN /_NN ml_NN (_( 3_CD nM_NN )_) and_CC
          becoming_VBG abundant_JJ at_IN 10_CD ng_NN /_NN ml_NN (_( 30_CD nM_NN )_) (_( Fig_NNP ._. 9_CD A_DT )_) ._. Adding_VBG
          PG_NNP F_NNP 
          2_CD α_NN at_IN the_DT same_JJ time_NN as_IN E_NNP 
          2_CD resulted_VBD in_IN a_DT reduction_NN of_IN the_DT
          number_NN of_IN foci_NN ._. Surprisingly_RB ,_, addition_NN of_IN PG_NNP D_NNP 
          2_CD also_RB resulted_VBD in_IN a_DT slight_JJ increase_NN
          in_IN focus_NN numbers_NNS (_( not_RB shown_VBN )_) ._.
          We_PRP next_RB attempted_VBD to_TO reverse_VB the_DT phenotype_NN seen_VBN in_IN
          clone_NN 11_CD cells_NNS ._. If_IN increased_VBN PG_NNP E_NNP 
          2_CD production_NN relative_JJ to_TO other_JJ PGs_NNP was_VBD
          responsible_JJ for_IN the_DT appearance_NN of_IN macroscopic_JJ foci_NN ,_, then_RB
          adding_VBG back_RB increasing_VBG amounts_NNS of_IN other_JJ PGs_NNP such_JJ as_IN D_NNP 
          2_CD and_CC F_NN 
          2_CD α_NN should_MD restore_VB the_DT phenotype_NN of_IN
          clone_NN 11_CD to_TO that_DT of_IN vector_NN only_RB controls_VBZ ._. As_IN PG_NNP F_NNP 
          2_CD α_NN attenuated_JJ the_DT focus_NN forming_VBG
          ability_NN of_IN PG_NNP E_NNP 
          2_CD in_IN the_DT experiment_NN shown_VBN in_IN Fig_NNP ._. 9_CD A_DT ,_,
          we_PRP added_VBD PG_NNP F_NNP 
          2_CD α_NN in_IN various_JJ concentrations_NNS to_TO clone_NN
          11_CD cells_NNS ._. PG_NNP F_NNP 
          2_CD α_NN at_IN 10_CD ng_NN /_NN ml_NN (_( 30_CD nM_NN )_) substantially_RB
          reduced_VBD the_DT focus_NN forming_VBG ability_NN of_IN IDO_NNP expressing_VBG clone_NN
          11_CD (_( Fig_NNP 9_CD B_NNP )_) ._. Thus_RB an_DT alteration_NN in_IN the_DT PG_NNP E_NNP 
          2_CD /_NN F_NN 
          2_CD α_NN ratio_NN plays_VBZ an_DT important_JJ role_NN in_IN
          mediating_VBG IDO_NNP 's_POS effects_NNS on_IN cell_NN growth_NN and_CC
          morphology_NN ._.
        
      
      
        Discussion_NNP
        Tryptophan_NNP catabolism_NN by_IN cells_NNS expressing_VBG IDO_NNP is_VBZ
        something_NN of_IN an_DT enigma_NN and_CC has_VBZ resulted_VBN in_IN speculation_NN as_IN
        to_TO why_WRB the_DT body_NN requires_VBZ two_CD enzymes_NNS with_IN different_JJ tissue_NN
        specificities_NNS to_TO degrade_NN the_DT rarest_NN essential_JJ amino_JJ acid_NN [_NN
        5_CD ,_, 34_CD ]_NN ._. The_DT inability_NN of_IN IDO_NNP to_TO be_VB induced_VBN by_IN its_PRP$ own_JJ
        substrate_NN exemplifies_VBZ this_DT puzzle_NN ._. While_IN IDO_NNP 's_POS role_NN in_IN
        controlling_VBG intracellular_NN pathogens_NNS is_VBZ well_RB documented_VBN ,_,
        there_EX is_VBZ little_JJ understanding_NN of_IN the_DT reasons_NNS for_IN IDO_NNP
        expression_NN at_IN sites_NNS in_IN the_DT body_NN unlikely_JJ to_TO be_VB related_VBN to_TO
        this_DT function_NN ,_, such_JJ as_IN the_DT epididymis_NNS ._. The_DT data_NNS we_PRP present_JJ
        here_RB reveal_VB that_IN IDO_NNP expression_NN is_VBZ an_DT important_JJ determinant_NN
        of_IN the_DT way_NN in_IN which_WDT cells_NNS interact_NN with_IN their_PRP$ extracellular_NN
        environment_NN 
        in_IN vitro_NN ._. In_IN particular_JJ ,_, cell_NN
        adhesion_NN is_VBZ altered_VBN dramatically_RB by_IN overexpressing_VBG IDO_NNP in_IN
        cells_NNS which_WDT do_VBP not_RB otherwise_RB express_VB it_PRP ,_, or_CC inhibiting_VBG IDO_NNP
        expression_NN in_IN cells_NNS in_IN which_WDT it_PRP is_VBZ naturally_RB induced_VBN
        following_VBG cell_NN passage_NN ._. Specifically_RB ,_, overexpression_NN of_IN IDO_NNP
        in_IN RAW_NNP and_CC MC_NNP 57_CD cells_NNS resulted_VBD in_IN the_DT growth_NN of_IN macroscopic_JJ
        foci_NN and_CC other_JJ phenotypic_JJ alterations_NNS ._. The_DT cell_NN foci_NN were_VBD
        multicellular_NN aggregates_NNS ,_, which_WDT grew_VBD vertically_RB as_RB well_RB as_RB
        horizontally_RB across_IN the_DT plate_NN surface_NN and_CC contained_VBD
        significant_JJ numbers_NNS of_IN necrotic_JJ cells_NNS within_IN their_PRP$
        interior_JJ ,_, as_IN judged_VBN by_IN trypan_NN blue_JJ exclusion_NN ._. Conversely_RB ,_,
        in_IN P_NN 19_CD cell_NN aggregates_NNS in_IN which_WDT IDO_NNP expression_NN was_VBD
        inhibited_VBD ,_, there_EX was_VBD a_DT more_JJR dispersed_VBD phenotype_NN with_IN cells_NNS
        losing_VBG the_DT ability_NN to_TO interact_NN with_IN each_DT other_JJ ._. We_PRP have_VBP
        recently_RB confirmed_VBN that_IN IDO_NNP expression_NN in_IN RAW_NNP cells_NNS
        following_VBG cell_NN passage_NN is_VBZ likewise_RB important_JJ for_IN correct_JJ
        cell_NN adhesion_NN (_( results_NNS not_RB shown_VBN )_) ._.
        Our_PRP$ data_NNS support_VBP the_DT hypothesis_NNS that_IN IDO-induced_NNP
        alterations_NNS in_IN PG_NNP synthesis_NN can_MD modify_VB cell_NN adhesion_NN ._. We_PRP
        observed_VBD changes_NNS in_IN the_DT relative_JJ amounts_NNS of_IN PGs_NNP in_IN
        IDO-transfected_NNP RAW_NNP cells_NNS and_CC reversal_NN of_IN the_DT effects_NNS of_IN
        IDO-expression_NNP by_IN PG_NNP F_NNP 
        2_CD α_NN while_IN PG_NNP E_NNP 
        2_CD stimulated_VBN focus_VB formation_NN ._. COX-_NNP 2_CD was_VBD
        upregulated_JJ in_IN IDO-expressing_NNP RAW_NNP cells_NNS ._. Similar_JJ effects_NNS of_IN
        PG_NNP E_NNP 
        2_CD on_IN cell_NN morphology_NN have_VBP recently_RB been_VBN
        reported_VBN in_IN the_DT human_JJ embryonic_JJ kidney_NN cell_NN line_NN HEK_NNP 293_CD ,_,
        which_WDT overexpressed_JJ COX-_NNP 2_CD and_CC PG_NNP E_NNP 
        2_CD synthase_NN [_NN 35_CD ]_NN ._. COX-_NNP 2_CD /_NN PG_NNP E_NNP 
        2_CD synthase-expressing_JJ cells_NNS were_VBD highly_RB
        aggregated_JJ ,_, piled_VBD up_RB and_CC exhibited_VBN round_NN shape_NN morphology_NN
        similar_JJ to_TO the_DT RAW_NNP cells_NNS described_VBD here_RB ._. MC_NNP 57_CD cells_NNS ,_, which_WDT
        demonstrated_VBD similar_JJ changes_NNS in_IN cell_NN adhesion_NN to_TO RAW_NNP cells_NNS
        following_VBG IDO_NNP expression_NN ,_, exhibited_VBN lower_JJR levels_NNS of_IN COX-_NNP 2_CD
        synthesis_NN upon_IN IDO_NNP expression_NN and_CC lower_JJR levels_NNS of_IN PG_NNP E_NNP 
        2_CD relative_JJ to_TO other_JJ PGs_NNP such_JJ as_IN D_NNP 
        2_CD ._. Furthermore_RB ,_, adding_VBG back_RB PGE_NNP 
        2_CD to_TO IDO-expressing_NNP MC_NNP 57_CD cells_NNS did_VBD not_RB
        reproduce_VB the_DT wild_JJ type_NN phenotype_NN (_( not_RB shown_VBN )_) ._. Thus_RB ,_,
        similar_JJ effects_NNS on_IN cell_NN morphology_NN were_VBD produced_VBN by_IN
        opposite_JJ effects_NNS on_IN COX-_NNP 2_CD expression_NN and_CC PG_NNP E_NNP 
        2_CD production_NN in_IN these_DT two_CD cell_NN lines_NNS ._. We_PRP
        are_VBP presently_RB attempting_VBG to_TO determine_VB if_IN products_NNS of_IN COX-_NNP 2_CD
        activity_NN other_JJ than_IN E_NNP 
        2_CD may_MD be_VB responsible_JJ for_IN IDO_NNP effects_NNS in_IN
        this_DT cell_NN line_NN ._.
        The_DT mechanism_NN of_IN PG-induced_NNP changes_NNS in_IN cell_NN adhesion_NN and_CC
        morphology_NN may_MD involve_VB MMP_NNP activity_NN ._. Synthesis_NNP of_IN MMPs_NNP such_JJ
        as_IN collagenase_NN I_PRP (_( MMP-_NNP 1_LS )_) ,_, gelatinase_NN B_NNP (_( MMP-_NNP 9_CD )_) and_CC
        matrilysin_NN (_( MMP-_NNP 7_CD )_) has_VBZ been_VBN shown_VBN to_TO be_VB dependent_JJ on_IN the_DT
        synthesis_NN of_IN PG_NNP E_NNP 
        2_CD ,_, suggesting_VBG that_IN alterations_NNS in_IN MMP_NNP
        expression_NN may_MD be_VB instigated_VBD by_IN alterations_NNS in_IN PG_NNP synthesis_NN
        [_NN 27_CD ,_, 28_CD ,_, 29_CD ,_, 30_CD ]_NN ._. Furthermore_RB ,_, both_DT COX-_NNP 1_CD and_CC COX-_NNP 2_CD have_VBP
        recently_RB been_VBN shown_VBN to_TO mediate_VB adhesion_NN of_IN various_JJ cell_NN
        types_NNS 
        in_IN vivo_NN and_CC 
        in_IN vitro_NN [_NN 36_CD ,_, 37_CD ]_NN ._. Thus_RB ,_, one_CD
        possibility_NN is_VBZ that_IN alterations_NNS in_IN MMP_NNP expression_NN and_CC
        activity_NN could_MD modify_VB cellular_JJ interactions_NNS with_IN the_DT
        extracellular_NN matrix_NN following_VBG IDO_NNP expression_NN ._. Consistent_NNP
        with_IN this_DT possibility_NN is_VBZ the_DT observation_NN that_IN MMP_NNP
        expression_NN in_IN P_NN 19_CD cells_NNS was_VBD correlated_JJ with_IN the_DT degree_NN of_IN
        IDO-antisense_NNP expression_NN ._. RAW_NNP transfectants_NNS over-expressing_JJ
        IDO_NNP showed_VBD reduced_VBN expression_NN of_IN collagenase_NN I_PRP (_( MMP-_NNP 1_LS )_) ,_, and_CC
        also_RB bound_VBN less_RBR well_RB to_TO collagen-coated_JJ plates_NNS than_IN
        controls_NNS ._. Collagen_NNP is_VBZ one_CD of_IN the_DT principal_JJ components_NNS of_IN
        the_DT extracellular_NN matrix_NN and_CC RAW_NNP cells_NNS bind_NN poorly_RB to_TO
        fibrillar_NN type_NN I_PRP collagen_NN unless_IN it_PRP is_VBZ denatured_JJ or_CC
        activated_VBN by_IN collagenase_NN [_NN 38_CD ]_NN ._. Thus_RB ,_, the_DT diminished_VBN
        expression_NN of_IN MMP-_NNP 1_CD in_IN IDO_NNP transfectants_NNS could_MD explain_VB
        their_PRP$ weaker_JJR binding_VBG to_TO this_DT substrate_NN ._. The_DT mechanism_NN by_IN
        which_WDT IDO_NNP regulates_VBZ prostaglandin_NN synthesis_NN is_VBZ yet_RB to_TO be_VB
        determined_VBN ._. Tryptophan_NNP is_VBZ a_DT stimulatory_NN co-factor_JJ for_IN COX_NNP
        and_CC degradation_NN of_IN tryptophan_NN in_IN the_DT intracellular_NN
        environment_NN could_MD alter_VB COX_NNP activity_NN ._. Alternatively_RB ,_, IDO_NNP
        might_MD influence_VB COX_NNP activity_NN and_CC expression_NN through_IN
        competition_NN for_IN or_CC release_NN of_IN heme_NN ,_, which_WDT both_DT enzymes_NNS
        require_VBP ._. 
        In_IN vitro_NN ,_, arachidonic_JJ acid_NN
        stimulates_NNS the_DT dissociation_NN of_IN heme_NN from_IN IDO_NNP and_CC this_DT
        correlates_NNS with_IN IDO_NNP stimulatory_NN effects_NNS on_IN COX_NNP [_NN 39_CD ]_NN ,_,
        providing_VBG circumstantial_JJ support_NN for_IN the_DT latter_JJ
        possibility_NN ._.
        The_DT alterations_NNS in_IN COX-_NNP 2_CD expression_NN observed_VBD in_IN
        IDO-expressing_NNP RAW_NNP and_CC MC_NNP 57_CD cells_NNS are_VBP a_DT particularly_RB
        interesting_JJ feature_NN of_IN our_PRP$ results_NNS ._. COX-_NNP 2_CD is_VBZ inducible_JJ by_IN a_DT
        number_NN of_IN inflammatory_JJ mediators_NNS including_VBG IFN-γ_NNP [_NN 40_CD ]_NN and_CC
        LPS_NNP [_NN 32_CD ]_NN ._. These_DT also_RB induce_VB IDO_NNP ._. Treatment_NNP of_IN
        IDO-expressing_NNP RAW_NNP clones_NNS with_IN a_DT known_VBN inducer_NN of_IN COX-_NNP 2_CD
        (_( LPS_NNP )_) ,_, revealed_VBD a_DT lack_NN of_IN correlation_NN between_IN COX-_NNP 2_CD RNA_NNP and_CC
        protein_NN levels_NNS ._. Clones_NNP 11_CD and_CC 22_CD showed_VBD low_JJ levels_NNS of_IN COX-_NNP 2_CD
        message_NN but_CC high_JJ levels_NNS of_IN protein_NN following_VBG LPS_NNP treatment_NN ._.
        This_DT suggests_VBZ that_IN COX-_NNP 2_CD RNA_NNP and_CC /_NN or_CC protein_NN turnover_NN may_MD be_VB
        affected_VBN by_IN IDO_NNP expression_NN ._. Other_JJ workers_NNS have_VBP noted_VBN that_IN
        non-steroidal_JJ anti-inflammatory_JJ drugs_NNS ,_, which_WDT inhibit_VBP COX_NNP
        activity_NN result_NN in_IN increased_VBN COX_NNP protein_NN expression_NN [_NN 41_CD ]_NN ,_,
        while_IN differences_NNS between_IN COX_NNP protein_NN expression_NN and_CC
        activity_NN have_VBP been_VBN reported_VBN to_TO be_VB produced_VBN by_IN some_DT
        cytokines_NNS ,_, including_VBG tumor_NN necrosis_NNS factor-α_JJ ,_, and_CC also_RB
        nitric_JJ oxide_NN donors_NNS [_NN 42_CD ,_, 43_CD ]_NN ._. Although_IN not_RB well_RB
        understood_VBN ,_, evidence_NN for_IN regulation_NN of_IN COX_NNP expression_NN at_IN
        the_DT post-transcriptional_JJ level_NN is_VBZ increasing_VBG [_NN 44_CD ,_, 45_CD ]_NN ._. The_DT
        down_JJ regulation_NN of_IN COX-_NNP 2_CD transcripts_NNS in_IN LPS-treated_NNP ,_,
        IDO-expressing_NNP RAW_NNP cells_NNS is_VBZ reminiscent_NN of_IN the_DT endotoxin_NN
        tolerance_NN effect_NN observed_VBD in_IN human_JJ THP-_NNP 1_CD promonocytic_JJ
        cells_NNS ._. Cells_NNP pretreated_JJ with_IN LPS_NNP and_CC thus_RB expressing_VBG COX-_NNP 2_CD
        showed_VBD down_RB regulation_NN of_IN COX-_NNP 2_CD mRNA_NN when_WRB subjected_VBN to_TO a_DT
        second_JJ LPS_NNP exposure_NN [_NN 46_CD ]_NN ._. In_IN addition_NN ,_, the_DT COX-_NNP 2_CD inhibitor_NN
        flufenamic_JJ acid_NN induced_VBD COX-_NNP 2_CD expression_NN in_IN RAW_NNP cells_NNS but_CC
        inhibited_VBD TNF-α_NNP or_CC LPS-induced_NNP COX-_NNP 2_CD expression_NN in_IN the_DT same_JJ
        cell_NN type_NN [_NN 47_CD ]_NN ._.
        As_IN both_DT MMPs_NNP and_CC COX-_NNP 2_CD are_VBP important_JJ factors_NNS in_IN tumor_NN
        development_NN [_NN 48_CD ,_, 49_CD ]_NN IDO_NNP 's_POS role_NN in_IN tumorigenesis_NNS bears_VBZ
        investigating_VBG ._. We_PRP have_VBP observed_VBN IDO_NNP expression_NN routinely_RB in_IN
        murine_NN tumors_NNS 
        in_IN vivo_NN ,_, and_CC are_VBP presently_RB
        investigating_VBG the_DT growth_NN properties_NNS of_IN tumors_NNS with_IN altered_VBN
        IDO_NNP expression_NN ._. In_IN addition_NN ,_, our_PRP$ recent_JJ work_NN indicates_VBZ a_DT
        role_NN for_IN IDO_NNP during_IN pregnancy_NN ._. Pharmacological_NNP inhibition_NN
        of_IN IDO_NNP results_NNS in_IN pronounced_VBN inflammation_NN ,_, complement_VB
        activation_NN and_CC fetal_JJ loss_NN [_NN 17_CD ,_, 50_CD ]_NN ._. Prostaglandins_NNP may_MD
        provide_VB a_DT common_JJ link_NN between_IN these_DT important_JJ biological_JJ
        phenomena_NNS ._.
      
      
        Conclusions_NNP
        IDO_NNP regulates_VBZ adhesion_NN of_IN cells_NNS to_TO normal_JJ growth_NN
        substrates_NNS ._. In_IN so_RB doing_VBG it_PRP modulates_NNS the_DT expression_NN and_CC
        activity_NN of_IN COX-_NNP 2_CD and_CC certain_JJ MMPs_NNP ._. RAW_NNP cells_NNS and_CC MC_NNP 57_CD
        cells_NNS overexpressing_VBG IDO_NNP grew_VBD as_IN multicellular_NN foci_NN ._. In_IN the_DT
        case_NN of_IN RAW_NNP cells_NNS ,_, this_DT was_VBD due_JJ to_TO elevated_VBD PGE_NNP relative_JJ to_TO
        other_JJ prostaglandins_NNS ._. P_NN 19_CD cells_NNS in_IN which_WDT endogenousIDO_NN
        expression_NN was_VBD disrupted_VBN by_IN antisense_NN expression_NN ,_, showed_VBD
        lower_JJR adhesiveness_NNS ._. Thus_RB ,_, tryptophan_NN catabolism_NN exerts_NNS
        control_VBP over_IN fundamental_JJ cellular_JJ functions_NNS ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Cells_NNP
          P_NN 19_CD cells_NNS were_VBD obtained_VBN from_IN the_DT American_NNP Type_NNP Culture_NNP
          Collection_NNP and_CC cultured_JJ as_IN described_VBN [_NN 23_CD ]_NN ._. Cells_NNP were_VBD
          differentiated_JJ into_IN myocytes_NNS or_CC neurones_NNS using_VBG 1_CD %_NN DMSO_NNP
          and_CC 10_CD -_: 6_CD M_NNP RA_NNP respectively_RB as_RB previously_RB reported_VBD [_NN 23_CD ,_,
          24_CD ]_NN ._. RAW_NNP 264_CD ._. 7_CD cells_NNS were_VBD a_DT gift_NN of_IN Dr_NNP ._. D_NNP ._. Greaves_NNP
          (_( Oxford_NNP ,_, England_NNP )_) and_CC were_VBD cultured_JJ in_IN Iscove_NNP 's_POS Modified_NNP
          Dulbecco_NNP 's_POS Medium_NNP supplemented_JJ with_IN 10_CD %_NN fetal_JJ calf_NN serum_NN ._.
          MC_NNP 57_CD cells_NNS were_VBD obtained_VBN from_IN Dr_NNP ._. Dimitrios_NNP Moskiphidis_NNP ,_,
          Medical_NNP College_NNP of_IN Georgia_NNP and_CC grown_VBN in_IN Iscove_NNP 's_POS Modified_NNP
          Dulbecco_NNP 's_POS Medium_NNP ._.
        
        
          IDO_NNP expression_NN
          A_DT full_JJ length_NN ,_, 1_CD ._. 2_CD kb_NN IDO_NNP cDNA_NN was_VBD amplified_VBN from_IN
          IFN-γ_NNP stimulated_VBN RAW_NNP cells_NNS and_CC cloned_VBN into_IN pGEM_NN T-E_NNP asy_NN
          (_( Promega_NNP )_) ,_, using_VBG primers_NNS ;_: 5_CD '_POS TAG_NNP CGG_NNP CCG_NNP CGT_NNP AGA_NNP CAG_NNP CAA_NNP
          TGG_NNP CAC_NNP TC_NNP 3_CD '_POS forward_RB ,_, 5_CD '_POS TAA_NNP GAT_NNP CTT_NNP ACA_NNP CTA_NNP AGG_NNP CCA_NNP ACT_NNP
          CAG_NNP 3_CD '_POS reverse_NN ,_, which_WDT contain_VBP Not_RB I_PRP and_CC Bgl_NNP II_NNP sites_NNS
          respectively_RB ._. The_DT 1_CD ._. 2_CD kb_NN IDO_NNP PCR_NNP fragment_NN was_VBD excised_VBN
          with_IN Not_RB I_PRP and_CC Bgl_NNP II_NNP and_CC cloned_VBN into_IN the_DT Not_RB I-B_NNP gl_NN II_NNP
          site_NN in_IN the_DT pDOI_NN vector_NN [_NN 51_CD ]_NN ,_, previously_RB modified_VBN by_IN the_DT
          introduction_NN of_IN a_DT Not_RB I_PRP site_NN in_IN front_NN of_IN the_DT Eco_NNP RI_NNP
          cloning_VBG site_NN ._. Plasmid_NNP DNA_NNP was_VBD linearized_JJ and_CC transfected_JJ
          into_IN RAW_NNP cells_NNS by_IN electroporation_NN ._. Stably_NNP transfected_JJ
          lines_NNS were_VBD selected_VBN in_IN 400_CD mg_NN /_NN ml_NN G_NNP 418_CD and_CC thereafter_RB
          maintained_VBN in_IN 200_CD mg_NN /_NN ml_NN G_NNP 418_CD ._. MC_NNP 57_CD cells_NNS were_VBD also_RB
          transfected_JJ by_IN electroporation_NN and_CC selected_VBN in_IN 1_CD ._. 2_CD mg_NN /_NN ml_NN
          G_NNP 418_CD ._.
        
        
          RT-PCR_NNP
          Analysis_NNP of_IN gene_NN expression_NN in_IN P_NN 19_CD or_CC RAW_NNP cells_NNS was_VBD
          performed_VBN using_VBG semi-quantitative_JJ RT-PCR_NNP ._. Total_NNP RNA_NNP was_VBD
          isolated_VBN from_IN cells_NNS using_VBG RNA_NNP STAT-_NNP 60_CD (_( Tel-_NNP Test_NNP Inc_NNP ._. )_) and_CC
          1_CD mg_NN was_VBD amplified_VBN for_IN 25_CD cycles_NNS unless_IN otherwise_RB stated_VBN ,_,
          following_VBG reverse_NN transcription_NN in_IN a_DT one_CD step_NN reaction_NN
          (_( RT-PCR_NNP "_'' Access_NNP "_'' ,_, Promega_NNP )_) ._. 5_LS μl_NN of_IN the_DT 50_CD ml_NN reaction_NN
          volume_NN was_VBD electrophoresed_JJ on_IN 0_CD ._. 8_CD %_NN agarose_NN gels_NNS prior_RB to_TO
          Southern_NNP blotting_VBG and_CC hybridization_NN with_IN a_DT specific_JJ
          probe_NN ._. Primers_NNP and_CC amplification_NN conditions_NNS for_IN IDO_NNP
          amplification_NN have_VBP been_VBN described_VBN elsewhere_RB [_NN 17_CD ]_NN ._.
          Primers_NNP for_IN amplification_NN of_IN other_JJ gene_NN specific_JJ
          transcripts_NNS were_VBD as_IN follows_VBZ ;_: stromelysin-_NN 1_CD ;_: 5_CD '_POS
          GATGACAGGGAAGCTGGA_NNP forward_RB ,_, 5_CD '_POS ACTGCGAAGATCCACTGA_NNP
          reverse_NN ._. Stromelysin-_NNP 2_CD ;_: 5_CD '_POS GATGTACCCAGTCTACAGGT_NNP 3_CD '_POS
          forward_RB ,_, 5_CD '_POS TGTCTTGTCTCATCATTACT_NNP 3_CD '_POS reverse_NN ._.
          Stromelysin-_NNP 3_CD ;_: 5_CD '_POS CTGCTGCTCCTGTTGCTGCT_NNP 3_CD '_POS forward_RB ,_, 5_CD '_POS
          ACCTTGGAAGAACCAAATC_NNP 3_CD '_POS reverse_NN ._. Meltrin-α_NNP ;_: 5_CD '_POS
          TGCATCAGTGGTCAGCCTCA_NNP 3_CD '_POS forward_RB ,_, 5_CD '_POS CTTTCTCTGCGGCCATTCTG_NNP
          3_CD '_POS reverse_NN ._. Meltrin-β_NNP ;_: 5_CD '_POS TTCAGTTTACACATCAGAC_NNP 3_CD '_POS forward_RB ,_,
          5_CD '_POS AGGTCACATTGCCGAACCT_NNP 3_CD '_POS reverse_NN ._. Collagenase_NNP I_PRP ;_: 5_CD '_POS
          GATTGTGAACTATACTCCT_NNP 3_CD '_POS forward_RB ,_, 5_CD '_POS CCATAGTCTGGTTAACATCA_NNP
          3_CD '_POS reverse_NN ._. Collagenase_NNP IV_NNP ;_: 5_CD '_POS GTATGGAGCGACGTCACT_NNP 3_CD '_POS
          forward_RB ,_, 5_CD '_POS CGCTCCAGAGTGCTGGCA_NNP 3_CD '_POS reverse_NN ._. GAPDH_NNP ;_: 5_CD '_POS
          TGCAGTGGCAAAGTGGAG_NNP 3_CD '_POS forward_RB 5_CD '_POS CCATCCACAGTCTTCTG_NNP 3_CD '_POS
          reverse_NN ._.
        
        
          Antisense_NNP inhibition_NN of_IN IDO_NNP expression_NN
          Constructs_NNP which_WDT expressed_VBD either_CC sense_NN or_CC antisense_NN
          IDO_NNP RNA_NNP were_VBD produced_VBN by_IN cloning_VBG a_DT 740_CD bp_NN RT-PCR_NNP fragment_NN
          of_IN the_DT IDO_NNP gene_NN ,_, described_VBD in_IN [_NN 17_CD ]_NN ,_, into_IN the_DT T-_NNP tailed_JJ
          cloning_VBG vector_NN pGEM_NN T-E_NNP asy_NN (_( Promega_NNP )_) ._. This_DT fragment_NN was_VBD
          excised_VBN with_IN Not_RB I_PRP and_CC subcloned_JJ into_IN the_DT Not_RB I_PRP site_NN of_IN
          the_DT mammalian_JJ expression_NN vector_NN pcDNA_NN 3_CD (_( Invitrogen_NNP )_) ,_, in_IN
          either_DT the_DT sense_NN or_CC antisense_NN orientation_NN ._. Following_VBG
          linearization_NN with_IN Bgl_NNP II_NNP ,_, the_DT constructs_NNS were_VBD
          transfected_JJ into_IN the_DT P_NN 19_CD cell_NN line_NN using_VBG Lipofectamine_NNP
          (_( Gibco-_NNP BRL_NNP )_) at_IN a_DT concentration_NN of_IN 25_CD μl_NN per_IN 100_CD ml_NN of_IN
          serum_NN free_JJ medium_NN ._. Stable_NNP transfectants_NNS were_VBD selected_VBN in_IN
          400_CD mg_NN /_NN ml_NN G_NNP 418_CD over_IN a_DT period_NN of_IN 4_CD weeks_NNS and_CC subsequently_RB
          maintained_VBN in_IN the_DT absence_NN of_IN G_NNP 418_CD in_IN normal_JJ growth_NN
          medium_NN ._. Periodic_NNP checks_NNS of_IN G_NNP 418_CD resistance_NN revealed_VBD no_DT
          significant_JJ loss_NN of_IN the_DT resistance_NN phenotype_NN ._.
          Confirmation_NNP that_IN resisitant_NN clones_NNS expressed_VBD IDO_NNP
          antisense_NN RNA_NNP was_VBD obtained_VBN by_IN isolating_VBG total_JJ RNA_NNP from_IN
          G_NNP 418_CD resistant_JJ clones_NNS ,_, treating_VBG with_IN ribonuclease_NN free_JJ
          DNase_NNP RQ_NNP 1_CD (_( Promega_NNP )_) and_CC reverse_VB transcribing_VBG RNA_NNP into_IN
          cDNA_NN in_IN the_DT presence_NN of_IN an_DT IDO_NNP sense_NN primer_NN [_NN 17_CD ]_NN ._. An_DT
          antisense_NN primer_NN was_VBD then_RB added_VBN and_CC the_DT cDNA_NN PCR_NNP
          amplified_VBN for_IN 25_CD cycles_NNS ._. Products_NNPS were_VBD electrophoresed_JJ in_IN
          0_CD ._. 8_CD %_NN agarose_NN ._.
        
        
          Western_NNP blotting_VBG
          RAW_NNP cells_NNS expressing_VBG IDO_NNP and_CC vector_NN only_RB controls_VBZ were_VBD
          harvested_VBN in_IN cell_NN lysis_NNS buffer_NN (_( PBS_NNP ,_, 1_CD %_NN NP_NNP 40_CD ,_, 0_CD ._. 5_CD %_NN sodium_NN
          deoxycholate_NN ,_, 0_CD ._. 1_CD %_NN SDS_NNP ,_, 150_CD ng_NN /_NN ml_NN PMSF_NNP ,_, 100_CD ng_NN /_NN ml_NN
          aprotinin_NN )_) and_CC 25_CD μg_NN of_IN cell_NN protein_NN was_VBD electrophoresed_JJ
          on_IN 10_CD %_NN polyacrylamide_NN gels_NNS overlayed_JJ with_IN a_DT 5_CD %_NN stacking_VBG
          gel_NN ._. Protein_NNP was_VBD quantitated_JJ using_VBG the_DT BCA_NNP assay_NN
          (_( Pierce_NNP )_) ._. COX-_NNP 1_CD and_CC COX-_NNP 2_CD antibodies_NNS (_( Santa_NNP Cruz_NNP
          Biotechnology_NNP Inc_NNP )_) were_VBD used_VBN in_IN combination_NN with_IN standard_JJ
          ECL_NNP techniques_NNS ._. Rabbit_NNP polyclonal_NN IDO-specific_NNP antibody_NN
          was_VBD generated_VBN against_IN a_DT C-_NNP terminal_NN peptide_NN of_IN 42_CD amino_JJ
          acids_NNS ;_: KPSKKKPTDGDKSEEPSNVESRGTGGTNPMTELRSVKDTTEK_NNP ._.
        
        
          Measurement_NNP of_IN tryptophan_NN depletion_NN by_IN HPLC_NNP
          Supernatants_NNP from_IN cell_NN cultures_NNS were_VBD extracted_VBN with_IN
          HPLC_NNP grade_NN methanol_NN and_CC analyzed_VBD on_IN a_DT Beckman_NNP Phenomenix_NNP
          C_NNP 18_CD (_( 2_LS )_) HPLC_NNP column_NN and_CC eluted_JJ with_IN a_DT 0_CD -_: 80_CD %_NN gradient_NN of_IN
          acetonitrile_NN over_IN 20_CD minutes_NNS ._. To_TO validate_NN retention_NN times_NNS
          and_CC for_IN the_DT construction_NN of_IN a_DT concentration_NN curve_NN a_DT
          standard_JJ mixture_NN of_IN kynurenine_NN and_CC tryptophan_NN was_VBD
          analyzed_VBN for_IN each_DT assay_NN ._.
        
        
          Analysis_NNP of_IN prostaglandin_NN production_NN
          Prostaglandin_NNP synthesis_NN was_VBD measured_VBN by_IN pulsing_VBG
          IDO-expressing_NNP RAW_NNP cells_NNS and_CC vector_NN only_RB controls_VBZ with_IN
          14_CD C_NNP arachidonic_JJ acid_NN (_( Sigma_NNP )_) ._. 5_LS ×_NN 10_CD 6_CD cells_NNS were_VBD
          harvested_VBN and_CC resuspended_JJ in_IN PBS_NNP and_CC incubated_JJ at_IN 37_CD °_NN C_NNP
          with_IN 1_CD ._. 3_CD mCi_NN arachidonic_JJ acid_NN (_( 53_CD mCi_NN /_NN mmol_NN )_) for_IN 30_CD mins_NNS ._.
          Following_VBG ether_NN extraction_NN ,_, samples_NNS were_VBD dissolved_VBN in_IN
          ethyl_NN acetate_NN and_CC spotted_VBD onto_IN thin_JJ layer_NN chromatography_NN
          plates_NNS ._. Plates_NNP were_VBD developed_VBN in_IN ethyl_NN acetate_NN :_: acetic_JJ
          acid_NN ,_, 90_CD :_: 1_CD ,_, together_RB with_IN unlabeled_JJ standards_NNS ._. Individual_JJ
          spots_NNS were_VBD excised_VBN from_IN the_DT chromatogram_NN and_CC
          radioactivity_NN determined_VBN by_IN scintillation_NN counting_NN ._.
        
        
          Cell_NNP adhesion_NN assay_NN
          Cell_NNP adhesion_NN assays_NNS were_VBD performed_VBN essentially_RB as_IN
          described_VBN [_NN 36_CD ]_NN ._. Briefly_NNP ,_, cells_NNS were_VBD seeded_VBN into_IN the_DT
          wells_NNS of_IN a_DT 24_CD well_RB plate_NN coated_VBN with_IN various_JJ growth_NN
          substrates_NNS Following_VBG incubation_NN at_IN 37_CD °_NN C_NNP ,_, for_IN 45_CD minutes_NNS ,_,
          cells_NNS unattached_JJ cells_NNS were_VBD removed_VBN by_IN PBS_NNP washes_NNS and_CC the_DT
          remaining_VBG cells_NNS were_VBD counted_VBN ._.
        
        
          Cell_NNP migration_NN assay_NN
          P_NN 19_CD cells_NNS in_IN log_NN phase_NN growth_NN were_VBD trypsinized_JJ and_CC 10_CD
          5_CD were_VBD seeded_VBN in_IN quadruplicate_NN into_IN Falcon_NNP cell_NN culture_NN
          inserts_NNS ,_, with_IN or_CC without_IN Matrigel_NNP coating_NN (_( Becton_NNP
          Dickinson_NNP ,_, Franklin_NNP Lakes_NNP ,_, NJ_NNP ,_, 8_CD ._. 0_CD μm_NN pore_NN size_NN ,_, 1_CD ×_NN 10_CD
          5_CD pores_VBZ /_NN sq_NN ._. cm_NN )_) ,_, in_IN a_DT volume_NN of_IN 0_CD ._. 2_CD ml_NN ,_, in_IN a_DT 24_CD well_RB tissue_NN
          culture_NN plate_NN ._. The_DT lower_JJR chamber_NN contained_VBD a_DT volume_NN of_IN
          0_CD ._. 8_CD ml_NN growth_NN medium_NN ,_, while_IN the_DT final_JJ volume_NN in_IN the_DT upper_JJ
          chamber_NN was_VBD 0_CD ._. 35_CD ml_NN ._. Chambers_NNP were_VBD incubated_JJ for_IN 18_CD hours_NNS
          after_IN which_WDT time_NN the_DT number_NN of_IN cells_NNS in_IN the_DT lower_JJR chamber_NN
          was_VBD determined_VBN ._.
        
        
          Image_NN analysis_NN
          The_DT size_NN of_IN individual_JJ P_NN 19_CD aggregates_NNS was_VBD determined_VBN
          by_IN capturing_VBG fields_NNS of_IN 40_CD -_: 50_CD aggregates_NNS at_IN 10_CD x_SYM
          magnification_NN and_CC then_RB calculating_VBG the_DT area_NN of_IN each_DT
          aggregate_JJ using_VBG the_DT NIH_NNP Image_NN (_( 1_CD ._. 62_CD )_) analysis_NN program_NN (_(
          http_NN :_: /_NN /_NN rsb_NN ._. info_NN ._. nih_NN ._. gov_NN /_NN nih-image_JJ /_NN download_NN ._. html_NN )_) ._.
        
      
      
        Abbreviations_NNP
        CMV_NNP :_: cytomegalovirus_JJ
        COX_NNP :_: cyclooxygenase_NN
        IDO_NNP :_: indoleamine_NN 2_CD ,_, 3_CD dioxygenase_NN
        IFN-γ_NNP interferon_NN gamma_NN
        LPS_NNP :_: lipopolysaccharide_NN
        MMP_NNP :_: matrix_NN metalloproteinase_NN
        NSAID_NNP :_: non-steroidal_JJ anti-inflammatory_JJ drug_NN
        PG_NNP :_: prostaglandin_NN
        TDO_NNP :_: tryptophan_NN 2_CD ,_, 3_CD dioxygenase_NN
      
    
  
